ketoconazole has been researched along with Communicable Diseases, Emerging in 2 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Communicable Diseases, Emerging: Infectious diseases that are novel in their outbreak ranges (geographic and host) or transmission mode.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trichet, E | 1 |
| Cohen-Bacrie, S | 1 |
| Conrath, J | 1 |
| Drancourt, M | 1 |
| Hoffart, L | 1 |
| Silva, V | 1 |
| Zepeda, G | 1 |
| Alvareda, D | 1 |
2 other studies available for ketoconazole and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Nocardia transvalensis keratitis: an emerging pathology among travelers returning from Asia.
Topics: Administration, Oral; Administration, Topical; Amikacin; Anti-Bacterial Agents; Antifungal Agents; C | 2011 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Res | 2003 |